Product NDC: | 61703-344 |
Proprietary Name: | Fludarabine Phosphate |
Non Proprietary Name: | FLUDARABINE PHOSPHATE |
Active Ingredient(s): | 50 mg/2mL & nbsp; FLUDARABINE PHOSPHATE |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 61703-344 |
Labeler Name: | Hospira Worldwide, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA077790 |
Marketing Category: | ANDA |
Start Marketing Date: | 20070406 |
Package NDC: | 61703-344-18 |
Package Description: | 1 VIAL, SINGLE-DOSE in 1 CARTON (61703-344-18) > 2 mL in 1 VIAL, SINGLE-DOSE |
NDC Code | 61703-344-18 |
Proprietary Name | Fludarabine Phosphate |
Package Description | 1 VIAL, SINGLE-DOSE in 1 CARTON (61703-344-18) > 2 mL in 1 VIAL, SINGLE-DOSE |
Product NDC | 61703-344 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | FLUDARABINE PHOSPHATE |
Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20070406 |
Marketing Category Name | ANDA |
Labeler Name | Hospira Worldwide, Inc. |
Substance Name | FLUDARABINE PHOSPHATE |
Strength Number | 50 |
Strength Unit | mg/2mL |
Pharmaceutical Classes | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |